The following section summarizes insights on PTC Therapeutics Inc's EPS Forecast (InvestingPro):
March 22, 2025: -
Performance Summary
PTC Therapeutics's eps forecast for the next fiscal year is -3.20
PTC Therapeutics's eps forecast is expected to average 0.59 over the next 5 fiscal years.
PTC Therapeutics's is expected to deliver median eps forecast of -0.31 over the next 5 fiscal years.
How does PTC Therapeutics's EPS Forecast (InvestingPro) benchmark against competitors?
Hide this widget
We've identified the following companies as similar to PTC Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
Positive EPS Revisions Ratio, Last 60 Days - Represents a ratio of analysts that have revised EPS forecasts upwards divided by a count of all analysts covering the company in the last 60 days (can be 0).
Press space bar to start a drag.
When dragging you can use the arrow keys to move the item around and escape to cancel.
Some screen readers may require you to be in focus mode or to use your pass through key